Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole M Arwood

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Pediatric Blood & Cancer|May 18, 2019
Universal premedication and therapeutic drug monitoring for asparaginase-based therapy prevents infusion-associated acute adverse events and drug substitutionsStacy L Cooper, David J Young, Caitlin J Bowen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chimeric Antigen Receptor T-Cell TherapyNdiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Pediatric Blood & Cancer|May 18, 2019
Universal premedication and therapeutic drug monitoring for asparaginase-based therapy prevents infusion-associated acute adverse events and drug substitutionsStacy L Cooper, David J Young, Caitlin J Bowen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chimeric Antigen Receptor T-Cell TherapyNdiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.
Pageof 1